Skip to main content Accessibility help

Impact of an Antimicrobial Utilization Program on Antimicrobial Use at a Large Teaching Hospital A Randomized Controlled Trial

  • Bernard C. Camins (a1), Mark D. King (a1), Jane B. Wells (a2), Heidi L. Googe (a2), Manish Patel (a2), Ekaterina V. Kourbatova (a1) (a3) and Henry M. Blumberg (a1) (a3)...



Multidisciplinary antimicrobial utilization teams (AUTs) have been proposed as a mechanism for improving antimicrobial use, but data on their efficacy remain limited.


To determine the impact of an AUT on antimicrobial use at a teaching hospital.


Randomized controlled intervention trial.


A 953-bed, public, university-affiliated, urban teaching hospital.


Patients who were given selected antimicrobial agents (piperacillin-tazobactam, levofloxacin, or vancomycin) by internal medicine ward teams.


Twelve internal medicine teams were randomly assigned monthly: 6 teams to an intervention group (academic detailing by the AUT) and 6 teams to a control group that was given indication-based guidelines for prescription of broad-spectrum antimicrobials (standard of care), during a 10-month study period.


Proportion of appropriate empirical, definitive (therapeutic), and end (overall) antimicrobial usage.


A total of 784 new prescriptions of piperacillin-tazobactam, levofloxacin, and vancomycin were reviewed. The proportion of antimicrobial prescriptions written by the intervention teams that was considered to be appropriate was significantly higher than the proportion of antimicrobial prescriptions written by the control teams that was considered to be appropriate: 82% versus 73% for empirical (risk ratio [RR], 1.14; 95% confidence interval [CI], 1.04-1.24), 82% versus 43% for definitive (RR, 1.89; 95% CI, 1.53-2.33), and 94% versus 70% for end antimicrobial usage (RR, 1.34; 95% CI, 1.25-1.43). In multivariate analysis, teams that received feedback from the AUT alone (adjusted RR, 1.37; 95% CI, 1.27-1.48) or from both the AUT and the infectious diseases consultation service (adjusted RR, 2.28; 95% CI, 1.64-3.19) were significantiy more likely to prescribe end antimicrobial usage appropriately, compared with control teams.


A multidisciplinary AUT that provides feedback to prescribing physicians was an effective method in improving antimicrobial use.

Trial Registration. identifier: NCT00552838.


Corresponding author

Emory University School of Medicine, Div of Infectious Diseases, 49 Jesse Hill Dr, Atlanta, GA 30303 (


Hide All
1.US Congress, Office of Technology Assessment. Impact of antibiotic-resistant bacteria (OTA-H-629), 1995. Washington, DC: US Government Printing Office, 1995.
2.Whitney, CG, Farley, MM, Hadler, J, et al.Increasing prevalence of mul-tidrug-resistant Streptococcus pneumoniae in the United States. N EnglJ Med 2000;343:19171924.
3.Fridkin, SK, Edwards, JR, Tenover, FC, Gaynes, RP, McGowan, JE Jr.Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis 2001;33:324330.
4.Fridkin, SK, Hill, HA, Volkova, NV, et al.Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis 2002;8:697701.
5.Neuhauser, MM, Weinstein, RA, Rydman, R, Danziger, LH, Karam, G, Quinn, JP. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003;289:885888.
6.Seppala, H, Klaukka, T, Vuopio-Varkila, J, et al.The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engi J Med 1997;337:441446.
7.Huovinen, P, Seppala, H, Kataja, J, Klaukka, T. The relationship between erythromycin consumption and resistance in Finland. Finnish Study Group for Antimicrobial Resistance. Ciba Found Symp 1997;207:3641.
8.Bronzwaer, SL, Cars, O, Buchholz, U, et al.A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2002;8:278282.
9.Monnet, DL, MacKenzie, FM, Lopez-Lozano, JM, et al.Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004;10:14321441.
10.Cohen, ML. Epidemiology of drug resistance: implications for a post-antimicrobialera. Science 1992;257:10501055.
11.Forum on Emerging Infections, Institute of Medicine. Antimicrobial Resistance: Issues and Options. Washington, DC: National Academy Press, 1998.
12.Kollef, MH, Fraser, VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001;134:298314.
13.Dunagan, WC, Woodward, RS, Medoff, G, et al.Antimicrobial misuse in patients with positive blood cultures. Am J Med 1989;87:253259.
14.Arbo, MD, Snydman, DR. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med 1994;154:26412645.
15.John, JF Jr, Fishman, NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997;24:471485.
16.Evans, RS, Pestotnik, SL, Classen, DC, et al.A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998;338:232238.
17.DeLisle, S, Perl, TM. Antimicrobial management measures to limit resistance: a process-based conceptual framework. Crit Care Med 2001;29: N121N127.
18.White, AC Jr, Atmar, RL, Wilson, J, Cate, TR, Stager, CE, Greenberg, SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997;25:230239.
19.Fraser, GL, Stogsdill, P, Dickens, JD Jr, Wennberg, DE, Smith, RP Jr, Prato, BS. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med 1997;157:16891694.
20.Solomon, DH, Van, HL, Glynn, RJ, et al.Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001;161:18971902.
21.Gross, R, Morgan, AS, Kinky, DE, Weiner, M, Gibson, GA, Fishman, NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001;33:289295.
22.Dranitsaris, G, Spizzirri, D, Pitre, M, McGeer, A. A randomized trial to measure the optimal role of the pharmacist in promoting evidence-based antibiotic use in acute care hospitals. Int J Technol Assess Health Care 2001;17:171180.
23.Shlaes, DM, Gerding, DN, John, JF Jr, et al.Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997;25:584599.
24.Goldmann, DA, Weinstein, RA, Wenzel, RP, et al.Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996;275:234240.
25.Bantar, C, Sartori, B, Vesco, E, et al.A hospital-wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003;37:180186.
26.Apisarnthanarak, A, Danchaivijitr, S, Khawcharoenporn, T, et al.Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin Infect Dis 2006;42:768775.
27.World Health Organization. ATC classification index with DDDs. Oslo, Norway: World Health Organization Collaborating Center for Drug Statistics Methodology, 2001.

Related content

Powered by UNSILO

Impact of an Antimicrobial Utilization Program on Antimicrobial Use at a Large Teaching Hospital A Randomized Controlled Trial

  • Bernard C. Camins (a1), Mark D. King (a1), Jane B. Wells (a2), Heidi L. Googe (a2), Manish Patel (a2), Ekaterina V. Kourbatova (a1) (a3) and Henry M. Blumberg (a1) (a3)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.